News and Trends 12 Sep 2022 Reveal Genomics reveals more HER2DX breast cancer validation data …HER2DX is the world’s first diagnostic test formulated specifically for HER2+ breast cancer. It is a standardized 27-gene expression test for patients with early-stage HER2+ breast cancer. HER2DX is a… September 12, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 26 Jul 2022 New AstraZeneca and Daiichi Sankyo breast cancer drug accepted by FDA …time a HER2-targeted therapy has shown a survival benefit in patients with HER2-low metastatic breast cancer. For more than two decades, only patients with HER2-positive breast cancer have been able… July 26, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 31 Jan 2023 Stemline Therapeutics’ breast cancer treatment approved …patients with ER+, HER2- metastatic breast cancer. This therapy targets the ESR1 mutations in metastatic breast cancer and provides patients with a convenient oral once-daily dose.” The Menarini Group obtained… January 31, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 6 Feb 2019 Combo of Immunotherapy and Diabetes Drug Could Beat Breast Cancer A Finnish research group has combined two cancer drugs with the diabetes drug metformin, making mice with breast cancer survive for longer than when given the treatments individually. The combination… February 6, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jun 2022 New data demonstrates clinical potential of Inivata’s RaDaR technology for breast cancer …(HER2) breast cancer. The company said its liquid biopsy platform unlocks essential genomic information from a simple blood draw, which may be used by clinicians to guide personalized cancer treatment… June 21, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 4 May 2023 Osteoporosis drug helps T cells fight aggressive breast cancer …deadly form of breast cancer, with limited treatment options and a high probability of recurrence. Tumor growth and relapse of TNBC are driven by breast cancer stem cells, and improved… May 4, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 15 Jan 2018 The FDA Gives AstraZeneca’s Breast Cancer Drug the Go-Ahead …diagnosed with breast cancer each day, making it the most common cancer in women and a very important target for new therapies. The BRCA1 and 2 genes encode tumor suppressor… January 15, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 19 Oct 2017 Personalized Breast Cancer Treatment Coming Soon with Help from Spanish Biotech …selective biomarker for breast cancer. A Phase III study demonstrated that breast cancer patients that would benefit from zoledronic acid therapy can be selected, helping clinicians offer the best treatment… October 19, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 21 Mar 2018 A Personalized Genetic Test for Breast Cancer Arrives in Europe …diagnostics, has obtained CE marking for the MammaPrint BluePrint Kit, a diagnostic device for breast cancer that uses next-generation sequencing technology. The kit can help clinicians identify women with breast… March 21, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 25 May 2017 Resilient Tumor Cells Drive Breast Cancer Relapse in Mice …metabolism in resilient cells to breast cancer relapse. “Our results suggest that residual cells retain an “oncogenic memory”; that could be exploited to develop drugs against breast cancer recurrence,” said… May 25, 2017 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Weekly Roundup 15 Dec 2023 Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered …the moment. The latest biotech news in clinical trials Genentech’s breast cancer trial reaps positive results American company Genentech owned by multinational pharmaceutical Roche, obtained positive results from a phase… December 15, 2023 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 13 Feb 2018 Erytech’s ‘Armed’ Red Blood Cells Will be Tested Against Triple Negative Breast Cancer …negative breast cancer, which makes up 10-20% of the 600,000 women that are diagnosed with breast cancer each year in Europe and the US. In addition, the decision was based… February 13, 2018 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email